Page last updated: 2024-08-26

phorbolol myristate acetate and Ovarian Neoplasms

phorbolol myristate acetate has been researched along with Ovarian Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harada, T; Itamochi, H; Kawaguchi, W; Kigawa, J; Kudoh, A; Naniwa, J; Nonaka, M; Oishi, T; Sato, S; Shimada, M; Terakawa, N; Uegaki, K	1
Bongarzone, I; Canevari, S; Fabbi, M; Ferrini, S; Mezzanzanica, D; Orengo, AM; Piazza, T; Puppo, A; Rossello, A; Rosso, O	1

Other Studies

2 other study(ies) available for phorbolol myristate acetate and Ovarian Neoplasms

Article	Year
Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:6 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Chromones; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Flavonoids; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Morpholines; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; S Phase; Tetradecanoylphorbol Acetate; Xenograft Model Antitumor Assays	2012
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. Molecular cancer research : MCR, 2007, Volume: 5, Issue:12 Topics: ADAM Proteins; ADAM17 Protein; Antigens, CD; Ascitic Fluid; Carcinogens; Cell Adhesion; Cell Adhesion Molecules, Neuronal; Cell Line, Tumor; Cell Movement; Culture Media, Conditioned; Enzyme Activation; Enzyme Inhibitors; Female; Fetal Proteins; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; RNA, Small Interfering; Solubility; Tetradecanoylphorbol Acetate; Vanadates	2007

Article

Year

Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2012, Volume: 22, Issue:6

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Chromones; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Flavonoids; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Morpholines; Ovarian Neoplasms; Phosphoinositide-3 Kinase Inhibitors; S Phase; Tetradecanoylphorbol Acetate; Xenograft Model Antitumor Assays

2012

The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells.

Molecular cancer research : MCR, 2007, Volume: 5, Issue:12

Topics: ADAM Proteins; ADAM17 Protein; Antigens, CD; Ascitic Fluid; Carcinogens; Cell Adhesion; Cell Adhesion Molecules, Neuronal; Cell Line, Tumor; Cell Movement; Culture Media, Conditioned; Enzyme Activation; Enzyme Inhibitors; Female; Fetal Proteins; Humans; Neoplasm Invasiveness; Ovarian Neoplasms; RNA, Small Interfering; Solubility; Tetradecanoylphorbol Acetate; Vanadates

2007